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Abstract 
An essential step for understanding the transcriptional circuits that control development 
and physiology is the global identification and characterization of regulatory elements. 
Here we present the first map of regulatory elements across the development and 
ageing of an animal, identifying 42,245 elements accessible in at least one ​C. elegans 
stage. Based on nuclear transcription profiles, we define 15,714 protein-coding 
promoters and 19,231 putative enhancers, and find that both types of element can drive 
orientation-independent transcription. Additionally, hundreds of promoters produce 
transcripts antisense to protein coding genes, suggesting involvement in a widespread 
regulatory mechanism. We find that the accessibility of most elements is regulated 
during development and/or ageing and that patterns of accessibility change are linked to 
specific developmental or physiological processes. The map and characterization of 
regulatory elements across ​C. elegans​ life provides a platform for understanding how 
transcription controls development and ageing. 
 
  
2 
.CC-BY 4.0 International licensepeer-reviewed) is the author/funder. It is made available under a
The copyright holder for this preprint (which was not. http://dx.doi.org/10.1101/279158doi: bioRxiv preprint first posted online Mar. 10, 2018; 
 Introduction 
The genome encodes the information for organismal life. Because the deployment of 
genomic information depends in large part on regulatory elements such as promoters 
and enhancers, their identification and characterization is essential for understanding 
genome function and its regulation.  
Regulatory elements are typically depleted for nucleosomes, which facilitates 
their identification using sensitivity to digestion by nucleases such as DNase I or Tn5 
transposase, termed DNA accessibility ​(Sabo et al. 2006; Crawford et al. 2006; 
Buenrostro et al. 2013)​. In different organisms, large repertoires of regulatory elements 
have been determined by profiling DNA accessibility genome-wide in different cell types 
and developmental stages ​(Thomas et al. 2011; Kharchenko et al. 2011; Thurman et al. 
2012; Yue et al. 2014; Roadmap Epigenomics Consortium et al. 2015; Daugherty et al. 
2017; Ho et al. 2017)​. However, no study has yet investigated regulatory element usage 
across the life of an animal, from the embryo to the end of life. Such information is 
important, because different transcriptional programs operate in different periods of life 
and ageing.​ C. elegans ​is ideal for addressing this question, as it has a simple anatomy, 
well defined cell types, and short development and lifespan. A map of regulatory 
elements and their temporal dynamics would facilitate understanding of the genetic 
control of organismal life. 
Active regulatory elements have previously been shown to have different 
transcriptional outputs and chromatin modifications ​(Andersson 2015; Kim and 
Shiekhattar 2015)​. Transcription is initiated at both promoters and enhancers, with most 
elements having divergent initiation events from two independent sites ​(Core et al. 2008; 
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 Kim et al. 2010; De Santa et al. 2010; Koch et al. 2011; Chen et al. 2013)​. However, 
promoters and enhancers differ in the production of stable transcripts. At protein-coding 
promoters, productive transcription elongation produces a stable transcript, whereas 
enhancers and the upstream divergent initiation from promoters generally produce short, 
aborted, unstable transcripts ​(Core et al. 2014; Andersson et al. 2014; Rennie et al. 
2017)​.  
Promoters and enhancers have also been shown to be differently enriched for 
specific patterns of histone modifications. In particular, promoters often have high levels 
of H3K4me3 and low levels of H3K4me1, whereas enhancers tend to have the opposite 
pattern of higher H3K4me1 and lower H3K4me3 ​(Heintzman et al. 2007, 2009)​. 
However, in human and Drosophila cell lines it was observed that H3K4me3 and 
H3K4me1 levels correlate with levels of transcription at regulatory elements, rather than 
whether the element acts as a promoter or an enhancer ​(Core et al. 2014; Henriques et 
al. 2018; Rennie et al. 2018)​. Further, analyses of genes that are highly regulated in 
development showed that their promoters lacked chromatin marks associated with 
activity (including H3K4me3), even when the associated genes are actively transcribed 
(Zhang et al. 2014; Pérez-Lluch et al. 2015)​. Therefore, stable elongating transcription, 
rather than histone modification patterns, appears to be the defining feature that 
distinguishes active promoters from active enhancers ​(reviewed in Andersson 2015; 
Andersson et al. 2015; Kim and Shiekhattar 2015; Henriques et al. 2018; Rennie et al. 
2018)​. 
Regulatory elements have not been systematically mapped and annotated in ​C. 
elegans​. Promoter identification has been hampered because the 5’ ends of ~70% of 
protein-coding transcripts are trans-spliced to a 22nt leader sequence ​(Allen et al. 2011)​. 
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 Because the region from the transcription initiation site to the trans-splice site (the 
“outron”) is removed and degraded, the 5’ end of the mature mRNA does not mark the 
transcription start site. To overcome this difficulty, previous studies identified 
transcription start sites for some genes through profiling transcription initiation and 
elongation in nuclear RNA or by inhibiting ​trans​-splicing at a subset of stages ​(Gu et al. 
2012; Chen et al. 2013; Kruesi et al. 2013; Saito et al. 2013)​. In addition, two recent 
studies used ATAC-seq or DNAse I hypersensitivity to map regions of accessible 
chromatin in some developmental stages, and predicted element function by proximity to 
first exons or chromatin state ​(Daugherty et al. 2017; Ho et al. 2017)​.  
Towards building a comprehensive map of regulatory elements and their use 
during the life of an animal, here we used multiple assays to systematically identify and 
annotate accessible chromatin in the six ​C. elegans ​developmental stages and at five 
time points of adult ageing. Strikingly, most elements undergo a significant change in 
accessibility during development and/or ageing. Clustering the patterns of accessibility 
changes in promoters reveals groups that act in shared processes. This map makes a 
major step towards defining regulatory element use during ​C. elegans​ life. 
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 Results and Discussion 
Defining and annotating regions of accessible DNA 
To define and characterize regulatory elements across ​C. elegans ​life, we collected 
biological replicate samples from a developmental time course and an ageing time 
course (Figure 1A). The developmental time course consisted of wild-type samples from 
each of the six developmental stages (embryos, four larval stages, and young adults). 
For the ageing time course, we used ​glp-1(e2144ts)​ mutants to prevent progeny 
production, as they lack germ cells at the restrictive temperature. Five adult ageing time 
points were collected, starting from the young adult stage (day 1) and ending at day 13, 
just before the major wave of death. 
Figure 1A outlines the datasets generated. For all developmental and ageing 
time points, we used ATAC-seq to identify accessible regions of DNA. We also 
sequenced strand-specific nuclear RNA (>200nt long) to determine regions of 
transcriptional elongation, because previous work demonstrated that this approach could 
capture outron signal linking promoters to annotated exons ​(Chen et al. 2013; Kruesi et 
al. 2013; Saito et al. 2013)​. For the development time course, we additionally sequenced 
short (<100nt) capped nuclear RNA to profile transcription initiation, profiled four histone 
modifications to characterize chromatin state (H3K4me3, H3K4me1, H3K36me3, and 
H3K27me3), and performed a DNase I concentration course to investigate the relative 
accessibility of elements. Micrococcal nuclease (MNase) data were also collected for the 
embryo stage. As previously noted by others, we found that the ATAC-seq accessibility 
signal is similar to that observed using a low concentration DNase I or MNase, and that 
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 the ATAC-seq data has the highest signal to noise ratio ​(Buenrostro et al. 2013; Figure 1 
- figure supplement 1A)​. 
To define sites that are accessible in at least one developmental or ageing stage, 
focal peaks of significant ATAC-seq enrichment were identified across all developmental 
and ageing samples, yielding 42,245 individual elements (Figure 1B, Figure 1 - source 
data 1; see Methods for details). Of these, 72.8% overlap a transcription factor binding 
site (TFBS) mapped by the modENCODE or modERN projects (Araya et al. 2014; 
Kudron et al. 2017), supporting their potential regulatory functions (Figure 2 - figure 
supplement 1A).  
Two recent studies reported accessible regions in ​C. elegans ​identified using 
DNase I hypersensitivity or ATAC-seq ​(Ho et al. 2017; Daugherty et al. 2017)​. The 
42,245 accessible elements defined here overlap 33.7% of ​(Ho et al. 2017)​ DNase I 
hypersensitive sites and 47.9% of ​(Daugherty et al. 2017)​ ATAC-seq peaks (Figure 2 - 
figure supplement 1B,C). Examining the non-overlapping sites from pairwise 
comparisons, it appears that differences in peak calling methods account for some of the 
differences. Accessible regions determined here required a focal peak of enrichment 
whereas the other studies found both focal sites and broad regions with increased 
signal. Consistent with these differences in methods, sites reported in the two studies but 
not identified here are enriched for exonic chromatin, depleted for both TFBS and 
transcription initiation sites, and often found in broad regions of increased accessibility 
across transcriptionally active gene bodies (Figure 2 - figure supplement 1B-E). 
To functionally classify elements, we annotated each of the 42,245 elements for 
transcription initiation and transcription elongation signals on both strands (Figure 2A; 
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 Figure 2 - source data 1; see Methods for details). Overall, 37.1% of elements had 
evidence of promoter activity, indicated by an increase in transcription elongation signal 
in at least one stage and one direction, and 82.3% of elements had transcription 
initiation signal. These patterns of nuclear transcription were used together with gene 
and ncRNA annotations to functionally separate the accessible elements into six 
classes: protein-coding promoter, pseudogene promoter, unknown promoter, putative 
enhancer, ncRNA (tRNA, snoRNA, rRNA, or miRNA), or other (Figure 2B). Elements 
were defined as promoters where there was a significant increase in transcription 
elongation signal originating at the element. Promoters were assigned to protein-coding 
or pseudogenes if there was continuous signal extending from the element to an 
annotated first exon (covering the outron). Promoters were annotated as “unknown” if 
transcription elongation signal was not linked to an annotated gene. Elements were 
annotated as putative enhancers where there was transcription initiation signal but no 
significant transcription elongation signal (hereafter referred to as “enhancers”). 
Elements were assigned to the ncRNA class if they overlapped an annotated tRNA, 
snoRNA, rRNA, or miRNA. Finally, elements with no transcriptional activity were 
annotated as “other”. Overall, accessible sites are enriched for being located within 
outrons or intergenic regions (Figure 2 - figure supplement 2A). 
Of the 42,245 elements, 13,596 were defined as protein-coding promoters: 
11,478 elements are unidirectional promoters and 2,118 are divergent promoters that 
drive expression of two oppositely oriented protein-coding genes (Figure 2 - source data 
1). In total, promoters were defined for 11,196 protein-coding genes, with 3,000 genes 
having >1 promoter (Figure 2C). The protein-coding promoter annotations show good 
overlap with four sets of TSSs previously defined based on mapping transcription ​(Chen 
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 et al. 2013; Kruesi et al. 2013; Saito et al. 2013; Gu et al. 2012; 76.8%–85.1%; Figure 2 - 
figure supplement 5)​. A further 19,231 elements were defined as enhancers. Enhancers 
were assigned to a gene if they are located within the region from its most upstream 
promoter to its gene end, with the rest left unassigned; 6,668 genes have at least one 
associated enhancer, and 3,240 genes have >1 enhancer (Figure 2C). 
The locations of unknown promoters suggest different potential functions. A large 
fraction (34.9%) generate antisense transcripts within the body of a protein coding gene, 
suggesting a possible role in regulating expression of the associated gene (Figure 2 - 
figure supplement 4). Another large group (41.1%) produce antisense transcripts from an 
element that is a protein coding promoter in the sense direction, a pattern seen in many 
mammalian promoters ​(Figure 2 - figure supplement 4; Preker et al. 2008; Flynn et al. 
2011; Sigova et al. 2013)​. Most of the rest (19.1%) are intergenic and may define 
promoters for unannotated transcripts. 
 
Patterns of histone marks at promoters and enhancers 
Promoters and enhancers show general differences in patterns of histone modifications, 
such as higher levels of H3K4me3 at promoters or H3K4me1 at enhancers, and 
chromatin states are frequently used to define elements as promoters or enhancers 
(Heintzman et al. 2007; Ernst and Kellis 2010; Ernst et al. 2011; Kharchenko et al. 2011; 
Hoffman et al. 2013; Daugherty et al. 2017)​. However it has been shown that H3K4me3 
levels correlate with transcriptional activity rather than with function ​(Pekowska et al. 
2011; Core et al. 2014; Andersson et al. 2014; Henriques et al. 2018; Rennie et al. 
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 2018)​, suggesting that defining regulatory elements solely based on chromatin state is 
likely to lead to incorrect annotations.  
To further investigate the relationship between chromatin marking and element 
function, we mapped four histone modifications at each developmental stage (H3K4me3, 
H3K4me1, H3K27me3, H3K36me3) and examined their patterns around coding 
promoters and enhancers. As expected, many coding promoters had high levels of 
H3K4me3 and were depleted for H3K4me1 (Figure 3A). Moreover, enhancers had 
generally low levels of H3K4me3 and higher levels of H3K4me1 than promoters (Figure 
3A). However many elements did not have these patterns. For example, about 50% of 
coding promoters have a high level of H3K4me1 and no or low H3K4me3 marking 
(Figure 3A).  
To investigate the nature of these patterns, we examined coefficients of variation 
of gene expression ​(CV; Gerstein et al. 2014)​ of the associated genes. Genes with 
broad stable expression across cell types and development, such as housekeeping 
genes, have low gene expression variation and hence a low CV value. In contrast, 
genes with regulated expression, such as those expressed only in particular stages or 
cell types have a high CV value. We found a strong inverse correlation between a gene’s 
CV value and its promoter H3K4me3 level (-0.64, Spearman's rank correlation; Figure 3; 
Figure 3 - figure supplement 1A). Furthermore, promoters with low or no H3K4me3 
marking are enriched for H3K27me3 (Figure 3; Figure 3 - figure supplement 1A), which 
is associated with regulated gene expression ​(Tittel-Elmer et al. 2010; Pérez-Lluch et al. 
2015; Evans et al. 2016)​. These results support the view that H3K4me3 marking may be 
a specific feature of promoters with broad stable activity, consistent with the finding that 
active promoters of regulated genes lack H3K4me3 ​(Pérez-Lluch et al. 2015)​. The 
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 profiling here was done in whole animals, which may have precluded detecting 
modifications occurring in a small number of nuclei. Nevertheless, the results indicate 
that chromatin state alone is not a reliable metric for element annotation. Histone 
modification patterns at many promoters resemble those at enhancers, and vice versa. 
Promoters and enhancers also share sequence features. Both are enriched for 
initiator INR elements, although enhancers have a slightly lower INR frequency (Figure 
3B). Promoters and enhancers show a similar level of enrichment for CpG dinucleotides, 
with the exception of promoters with high H3K4me3 and low CV values (broadly 
expressed genes), which have higher CpG content than other elements (Figure 3B and 
Figure 3 - figure supplement 1B). As expected from other studies, promoters also differ 
from enhancers by the presence of TATA motifs, which occur predominantly in genes 
with low H3K4me3 and high CV values (i.e., with regulated expression; Figure 3B and 
Figure 3 - figure supplement 1B). 
 
Promoters and enhancers can drive gene expression in an orientation 
independent manner 
To validate the promoter annotations, we compared them with studies where small 
regions of DNA had been defined as promoters using transgenic assays. These 
comprised ten regions defined based on transcription initiation signal ​(Chen et al. 2014)​, 
nine regions defined based on proximity to a germ line gene ​(Merritt et al. 2008)​, and 
four defined by proximity to the first exon of a muscle expressed gene ​(Hunt-Newbury et 
al. 2007)​. Of these 23 regions, 21 overlap an element in our set of accessible sites, 19 of 
which are annotated as protein coding promoters (Figure 2 - Figure supplement 5A). 
One of the remaining two is annotated as an enhancer and the other overlaps an 
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 accessible element for which no transcriptional signal was detected. We further directly 
tested three elements annotated as promoters (for ​hlh-2, ztf-11 ​and ​bed-3 ​ genes), and 
found that all three drove robust expression of a histone-GFP reporter (Figure 2 - figure 
supplement 5A). Overall, there is good concordance between promoter annotation and 
promoter activity. 
Most of the elements annotated as protein-coding promoters are flanked by 
bidirectional transcription initiation signal (74.0%), similar to the pattern seen in 
mammals. Most (82.6%) are unidirectional promoters, producing a protein-coding 
transcript in one direction, but no stable transcript from the upstream initiation site. To 
test whether such upstream antisense initiation sites could function as promoters, we 
inverted the orientation of two of the unidirectional promoters found to be active (​ztf-11 
and F58D5.5). If the lack of ​in vivo ​transcription elongation was a property of the element 
or initiation site itself, the GFP fusion should not be expressed. However, we observed 
that the two inverted unidirectional promoters both drove GFP expression. The 
expression patterns generated were similar in both orientations, although one was 
weaker when inverted (Figure 2 - figure supplements 6B,C). These results suggest that 
signals for productive elongation occur downstream of the transcription initiation site.  
Similar to the upstream antisense transcription initiation observed at promoters, 
enhancers also show transcription initiation signals but generally do not produce stable 
transcripts ​(Core et al. 2014; Andersson et al. 2014)​. Previous studies have reported that 
some enhancers can function as promoters in transgenic assays and also at 
endogenous loci ​(Kowalczyk et al. 2012; Leung et al. 2015; Nguyen et al. 2016; van 
Arensbergen et al. 2016; Mikhaylichenko et al. 2018)​. To assess the potential promoter 
activities of ​C. elegans ​enhancers, we directly fused 12 putative enhancers that had 
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 transcription initiation signal in embryos to a histone-GFP reporter gene and assessed 
transgenic strains for embryo expression. Two of the tested enhancers are located in 
introns, and one of these, from the ​bro-1 ​ gene, has been previously validated as an 
enhancer ​(Brabin et al. 2011)​; most of the others are associated with the ​hlh-2 ​ or ​ztf-11 
genes. We found that 10 of 12 tested regions drove reporter expression in embryos, 
including the two intronic enhancers (Figure 2 - figure supplement 5B,C). Whereas the 
hlh-2 ​ and ​ztf-11 ​ promoters drove strong, broad expression, the associated enhancers 
were active in a smaller number of cells and expression levels were overall lower 
(Figure 2 - figure supplement 6B,C). We also tested two enhancers in inverted 
orientation and found that both showed similar activity in both orientations, as observed 
for the two tested promoters (Figure 2 - figure supplement 5B,C). The percentage of 
enhancers that functioned as active promoters is higher than that observed in a cell 
based assay ​(Nguyen et al. 2016)​, possibly because all cell types are tested in an intact 
animal. Episomal based assays have also been reported to underestimate activity ​(Inoue 
et al. 2016)​. 
 
Extensive regulation of chromatin accessibility in development 
We observed that chromatin accessibility is highly dynamic across development, with 
most elements showing a significant change within the developmental time course (71%, 
>=2-fold change, FDR<0.01; Figure 4 - source data 1; see Methods). To investigate how 
accessibility relates to gene expression, we focused on the 13,596 elements annotated 
as protein-coding promoters. Of these, 10,199 displayed significant changes in 
accessibility in development, with the remaining 3397 promoters classified as having 
stable accessibility. 
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 We defined 16 clusters of promoters with shared accessibility dynamics in 
development (Figure 4A and Figure 4 - figure supplement 1; Figure 4 - source data 1; 
Methods). Within clusters, we observed that promoter accessibility and nuclear RNA 
levels are usually correlated (mean r=0.47 (sd=0.11) across all clusters), indicating that 
accessibility is a good metric of promoter activity and overall gene expression (Figure 4 - 
figure supplement 1). 
The shared patterns of developmental accessibility suggest that promoters within 
each cluster may control genes involved in common processes. To explore this 
possibility, we took advantage of recent single cell profiling data obtained from L2 larvae, 
which provides gene expression measurements for different tissues ​(Cao et al. 2017)​. 
We find that half of the developmental promoter clusters are enriched for genes with 
tissue biased expression (Figure 4A and Figure 4 - figure supplement 1). Based on these 
patterns of enrichment, we defined four gonad clusters (G1-G4), two intestine clusters 
(I1, I2), one hypodermal cluster (H) and one cluster enriched for neural and muscle 
genes (N+M) (Figure 4A and Figure 4 - figure supplement 1). Genes associated with the 
remaining eight clusters (Mix1–8) are generally expressed in multiple tissues, but 
predominantly in the soma (Figure 4A and Figure 4 - figure supplement 1). As expected, 
genes linked to the stable promoters are widely expressed (Figure 4A and Figure 4 - 
figure supplement 1). Interestingly, clusters associated with the same tissues-specific 
profiles can exhibit similar variations in accessibility but with different amplitude. For 
instance, gonad clusters G1 and G2 both show a sharp increase in accessibility at the L3 
stage, however the increase is 1.5-fold larger in G2 than in G1. The gonad clusters are 
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 generally characterized by an increase of promoter accessibility starting in L3 when 
germ cell number strongly increases. 
To further investigate promoter clusters sharing accessibility dynamics, we 
performed Gene Ontology analyses on the associated genes. As expected, we found 
that clusters containing genes enriched for expression in a particular tissue are also 
associated with GO terms related to that tissue (Figure 4C and Figure 4 - figure 
supplement 1). For instance, cluster H contains genes highly expressed in hypodermis 
and GO terms linked to cuticle development.  Of note, the four accessibility clusters 
enriched for expression in germ line are associated with GO terms for different sets of 
germ line functions (Figure 4 - figure supplement 1). Similarly, the two intestinal clusters 
also identify genes with different types of intestinal function. Furthermore, accessibility 
dynamics can reflect the temporal function of the associated promoters. For instance, 
cluster Mix4 has GO terms indicative of neuronal development and highest accessibility 
in the embryo, when many neurons develop. These results suggest that promoter 
clusters contain genes acting in a shared process and having a similar mode of 
regulation.  
To identify potential transcriptional regulators, we asked whether the binding of 
particular transcription factors is enriched in any promoter clusters, using TF binding 
data from the modENCODE and modERN projects ​(Boyle et al. 2014; Kudron et al. 
2017)​. TFs with enriched binding were found for each cluster, and the expression of 
such TFs was generally enriched in the expected tissue (Figure 5A ; Methods). For 
example, ELT-2, an intestine specific GATA protein ​(Fukushige et al. 1998)​, has 
enriched binding at promoters of intestinal clusters 1 and 2. Similarly, hypodermal 
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 transcription factors BLMP-1 ​(Horn et al. 2014)​, NHR-25 ​(Gissendanner and Sluder 
2000)​ and ELT-3 ​(Gilleard et al. 1999)​ are enriched in the hypodermal promoter cluster, 
and germ line XND-1 transcription factor ​(Wagner et al. 2010)​ is enriched in the germ 
line clusters of promoters. Following this approach, we identified novel tissue-specific 
associations for uncharacterized transcription factors, such as ZTF-18 and ATHP-1 with 
promoters of germ line clusters and CRH-2 with the intestinal clusters (Figure 5A). Taken 
together, the results suggest that promoters with shared accessibility patterns have 
shared cell-type specific activity, and they highlight potential regulators that are 
candidates for future studies.  
 
Analysis of Ageing clusters 
We next focused on chromatin accessibility changes during ageing. In contrast to the 
development time course, the accessibility of most promoters is stable during ageing, 
with only 13% (n=1,800) of promoters showing changes (Figure 4 - source data 1). 
Interestingly, 75% of these also had regulated accessibility in development. 
As for the development time course, we clustered accessibility changes in 
ageing. We identified eight clusters of promoters with similar accessibility changes 
across ageing and annotated them based on tissue biases in gene expression 
(Figure 4B; Figure 4 - source data 1). This defined one intestinal cluster (I), two clusters 
enriched for intestine or hypodermal biased expression (I+H) and 5 mixed clusters. 
Several mixed clusters show weak gene expression enrichments, such as intestine 
expression in Mix1-2 and neural expression in Mix3 (Figure 4B). As observed for the 
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 development clusters, enriched GO terms were consistent with gene expression biases 
(Figure 4B, Figure 4 - figure supplement 2). 
We then evaluated the enrichment of transcription factors at each ageing 
promoter cluster. The binding of DAF-16/FoxO, a master regulator of ageing ​(Lin et al. 
2001)​, is associated with four ageing promoter clusters (Figure 5B). Consistent with a 
prominent role in the intestine ​(Figure 4B; Kaplan and Baugh 2016)​, promoter clusters 
enriched for DAF-16 binding are enriched for intestinal genes (Figure 4B). The binding 
enrichment patterns of five other TFs implicated in ageing (DVE-1, NHR-80, ELT-2, 
FOS-1 and PQM-1 ​(Uno et al. 2013; Folick et al. 2015; Goudeau et al. 2011; Mann et al. 
2016; Tian et al. 2016; Mao et al. 2016; Tepper et al. 2013)​ are similar to DAF-16 (Figure 
5B). These TFs and DAF-16 are also enriched in developmental intestine promoter 
clusters (Figure 5A), supporting cooperation in development and ageing. A group of 
hypodermal TFs including BLMP-1, ELT-1 and ELT-3 are found enriched at promoters in 
the two I + H ageing clusters (Figure 5B). Finally, CEPB-1 binding is enriched in clusters 
Mix3 and Mix4, which are characterized by a continuous increase of promoter 
accessibility across ageing. This suggests a potential role of CEBP-1 in activating a 
subset of genes during ageing, as it is the case for its homologue CEBP-β in mouse 
(Sandhir and Berman 2010)​. 
 
Conclusion 
For the first time, we systematically map regulatory elements across the lifespan of an 
animal. We identified 42,245 accessible sites in ​C. elegans​ chromatin and functionally 
annotated them based on transcription patterns at the accessible site. This avoided the 
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 problems of histone-mark based approaches for defining element function ​(Core et al. 
2014; Henriques et al. 2018; Rennie et al. 2018)​. Our map identified promoters active 
across development and ageing, but we did not find promoters for every gene. Classes 
that would have been missed are those for genes expressed only in males or dauer 
larvae (which we did not profile) and genes not active under laboratory conditions. In 
addition, whole-animal profiling would miss promoters active in only a small number of 
cells. In the future, assaying accessible chromatin and nuclear transcription in specific 
cell types should identify many of these missed elements. 
We found that accessibility of most elements changes during the life of the worm, 
supporting a key role played by chromatin structure. Despite the map being based on 
bulk profiling in whole animals, we find that regulatory elements with shared accessibility 
dynamics often share patterns of tissue-specific expression, GO annotation, and TF 
binding. The promoters within clusters are therefore excellent starting points for studies 
of cell- and process-specific gene expression. In summary, our identification of 
regulatory elements across ​C. elegans​ life together with an initial characterisation of their 
properties provides a key resource that will enable future studies of transcriptional 
regulation in development and ageing.  
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 Methods 
Collection of developmental time series samples 
Wild-type N2 were grown at 20°C in liquid culture to the adult stage using standard 
S-basal medium with HB101 bacteria, animals bleached to obtain embryos, and the 
embryos hatched without food in M9 buffer for 24 hrs at 20°C to obtain synchronized 
starved L1 larvae. L1 larvae were grown in a further liquid culture at 20°C to the desired 
stage, then collected, washed in M9, floated on sucrose, washed again in M9, then 
frozen into "popcorn" by dripping embryo or worm slurry into liquid nitrogen. Popcorn 
were stored at -80°C until use. Times of growth were L1 (4 hrs), L2 (20 hrs), L3 (30 hrs), 
L4 (45 hrs), young adults (60 hrs). Mixed populations of embryos were collected by 
bleaching cultures of synchronized one day old adults. 
 
Collection of ageing time series samples 
glp-1(e2144)​ were raised at 15°C on standard NGM plates seeded with OP50 bacteria. 
Embryos were obtained by bleaching gravid adults and then approximately 6000 placed 
at 25°C on 150mm 2% NGM plates seeded with a 30X concentrated overnight culture of 
OP50. For harvest, worms were washed 3X in M9 and then worm slurry was frozen into 
popcorn by dripping into liquid nitrogen and stored at -80°C. Harvest times after embryo 
plating were D1/YA (53 hrs), D2 (71 hrs), D6 (167 hrs), D9 (239 hrs), D13 (335 hrs). 
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 Nuclear isolation and ATAC-seq 
Frozen embryos or worms (1–3 frozen popcorns) were broken by grinding in a mortar 
and pestle or smashing using a Biopulverizer, then the frozen powder was thawed in 10 
ml Egg buffer (25 mM HEPES pH 7.3, 118 mM NaCl, 48 mM KCl, 2 mM CaCl2, 2 mM 
MgCl2). Ground worms were pelleted by spinning at 1500 g for 2 minutes, then 
resuspended in 10ml working Buffer A (0.3M sucrose, 10 mM Tris pH 7.5, 10 mM 
MgCl2, 1mM DTT, 0.5 mM spermidine 0.15 mM spermine, protease inhibitors (Roche 
complete, EDTA free) containing 0.025% IGEPAL CA-630. The sample was dounced 
10X in a 14ml stainless steel tissue grinder (VWR), then the sample spun 100g for 6 min 
to pellet large fragments. The supernatant was kept and the pellet resuspended in a 
further 10 ml Buffer A, then dounced for 25 strokes. This was spun 100g for 6 min to 
pellet debris and the supernatants, which contain the nuclei, were pooled, spun again at 
100g for 6 min to pellet debris, and transferred to a new tube. Nuclei were counted using 
a hemocytometer. One million nuclei were transferred to a 1.5 ml tube and spun 2000g 
for 10min to pellet. ATAC-seq was performed essentially as in (Buenrostro et al. 2013). 
The supernatant was removed, the nuclei resuspended in 47.5 ul of tagmentation buffer, 
incubated for 30 minutes at 37°C with 2.5 ul Tn5 enzyme (Illumina Nextera kit), and then 
tagmented DNA purified using a MinElute column (Qiagen) and converted into a library 
using the Nextera kit protocol. Typically, libraries were amplified using 12–16 PCR 
cycles. ATAC-seq was performed on two biological replicates for each developmental 
stage and each ageing time point. 
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 DNAse I and MNase mapping 
Replicate concentration courses of DNase I were performed for each stage as follows. 
Twenty million nuclei were digested in Roche DNAse I buffer for 10 minutes at 25C using 
2.5, 5, 10, 25, 50, 100, 200, and 800 units/ml DNase I (Roche), then EDTA was added to 
stop the reactions. Embryo micrococcal nuclease (MNase) digestion concentration 
courses for embryos were made by digesting nuclei with 0.025, 0.05, 0.1, 0.25, 0.5, 1, 4, 
8, or 16 units/ml MNase in 10mM Tris pH 7.5, 10mM MgCl2, 4mM CaCl2 for 10 minutes 
at 37C. Reactions were stopped by the additon of EDTA. Following digestions, total DNA 
was isolated from the nuclei following proteinase K and RNase A digestion, then large 
fragments removed by binding to Agencourt AMPure XP beads (0.5 volumes). Small 
double cut fragments < 300 bp were isolated either using a Pippen prep gel (protocol 1) 
or using Agencourt AMPure XP beads (protocol 2). DNA was converted into sequencing 
libraries using the Illumina Truseq kit or a homemade equivalent.  
 
Transcription initiation and nuclear RNA profiling 
Nuclei were isolated and then chromatin associated RNA (development series) or 
nuclear RNA (ageing series) was isolated. Chromatin associated RNA was isolated as in 
(Pandya-Jones and Black 2009)​, resuspending washed nuclei in Trizol for RNA 
extraction. To isolate nuclear RNA, nuclei were directly mixed with Trizol. Following 
purification, RNA was separated into fractions of 17–200nt and >200nt using Zymo clean 
and concentrate columns. To profile transcription elongation ("long cap RNA-seq") in the 
nucleus, stranded libraries were prepared from the >200nt RNA fraction using the NEB 
Next Ultra Directional RNA Library Prep Kit (#E7420S). Libraries were made from two 
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 biological replicates for each developmental stage and each ageing time point. To profile 
transcription initiation ("short cap RNA-seq"), stranded libraries were prepared from the 
17–200nt RNA fraction. Non-capped RNA was degraded by first converting uncapped 
RNAs into 5’-monophosphorylated RNAs using RNA polyphosphatase (Epibio), then 
treating with 5' Terminator nuclease (Epibio). The RNA was treated with calf intestinal 
phosphatase to remove 5’ phosphates from undegraded RNA, and decapped using 
Tobacco Acid Pyrophosphatase (Epicentre), Cap-Clip Acid Pyrophosphatase (CellScript, 
for one L2 and one L3 replicate) or Decapping Pyrophosphohydrolase, (Dpph tebu-bio, 
for one L3 replicate) and then converted into sequencing libraries using the Illumina 
TruSeq Small RNA Preparation Kit kit. Libraries were size selected to be 145–225 bp 
long on a 6% acrylamide gel, giving inserts of 20–100 bp long. Libraries were made from 
two biological replicates for each developmental stage. During the course of this work, 
the TAP enzyme stopped being available; the Cap-Clip and Dpph enzymes perform less 
well than TAP. One L3 and one YA replicate was made using a slightly different protocol. 
Embryo short cap RNA-seq data from ​(Chen et al. 2013)​ was also included in the 
analyses (GSE42819). 
 
ChIP-seq 
Balls of frozen embryos or worms were ground to a powder using a mortar and pestle or 
a Retch Mixer Mill to break animals into pieces. Frozen powder was thawed into 1% 
formaldehyde in PBS, incubated 10 minutes, then quenched with 0.125M glycine. Fixed 
tissue was washed 2X with PBS plus protease inhibitors, once in FA buffer, then 
resuspended in 1ml FA buffer per 1 mL of ground worm powder and the extract 
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 sonicated to an average size of 200 base pairs with a Diagenode Bioruptor or Bioruptor 
Pico for 25 pulses of 30 seconds followed by 30 seconds pause. For ChIP, 500ug 
protein extract was incubated 2ug antibody in FA buffer with protease inhibitors 
overnight at 4°C, then incubated with magnetic beads conjugated to secondary 
antibodies for 2hrs at 4°C. Magnetic beads bound to immunoprecipitate were washed at 
room temperature twice in FA+protease inhibitors (50mM Hepes pH7.5, 1mM EDTA, 1% 
TritonX-100, 0.1% sodium deoxycholate, and 150mM NaCl), then once each in FA with 
0.5M NaCl, FA with 1M NaCl, 0.25M LiCl (containing 1% NP-40, 1% sodium 
deoxycholate, 1mM EDTA, 10mM Tris pH8) and finally twice with TE pH8. 
Immunoprecipitated DNA was then eluted at twice with 1%SDS, 250mM NaCl, 10mM 
Tris pH8, 1mM EDTA at 65°C. Eluted DNA was treated with RNase for 30min at 37C 
and crosslinks reversed by overnight incubation at 65°C with 200ug/ml proteinaseK, and 
the DNA purified using a Qiagen column. Following ChIP and DNA purification, libraries 
were prepared using the Illumina TruSeq kit. Fragments in the 250–350 base pair range 
were selected using Agencourt AMPure XP beads. Two biological replicate ChIPs were 
conducted for each histone modification at each developmental time point (Embryo, L1, 
L2, L3, L4, YA). Antibodies used were: anti-H3K4me3 (Abcam ab8580, GR273043-4), 
anti-H3K4me1 (Abcam ab8895, GR149140-2), anti-H3K36me3 (Abcam ab9050, lot 
GR288636-2), and anti-H327me3 (Wako 309-95259). 
 
Data processing 
The WBcel215/ce10 (WS220) version of the ​C. elegans​ genome was used throughout 
the study. Reads were aligned using bwa-backtrack (H. Li and Durbin 2009) in 
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 single-end (ATAC-seq, short cap RNA-seq, ChIP-seq) or paired-end mode (ATAC-seq - 
developmental only, DNase-seq, MNase-seq, long cap RNA-seq). Low-quality (q < 10), 
mitochondrial and modENCODE-blacklisted (Boyle et al., 2014) reads were discarded at 
this point. 
For ATAC-seq, normalised genome-wide accessibility profiles from single-end 
reads were then calculated with MACS2 (Zhang et al. 2008) using the parameters 
--format BAM --bdg --SPMR --gsize ce --nolambda --nomodel --extsize 150 --shift -75 
--keep-dup all. Developmental ATAC-seq was also processed in paired-end mode 
(ATAC-seq libraries of ageing samples were single-end). We did not observe major 
differences between accessible sites identified from paired-end, and single-end profiles, 
and therefore use single-end profiles throughout the study for consistency. 
Short cap and long cap data was processed essentially as in (Chen et al. 2013). 
Following alignment, and filtering, transcription initiation was represented using 
strand-specific coverage of 5’ ends of short cap reads. Transcription elongation was 
represented as strand-specific coverage of long cap reads, with regions between read 
pairs filled in. For browsing, transcription elongation signal was normalised between 
samples by sizeFactors calculated from gene-level read counts using DESeq2 (Love, 
Huber, and Anders 2014). Normalised (linear) coverage signal was then further 
log-transformed with .og (normalised_coverage )l 2 + 1  
ChIP-seq data was processed as in (Chen et al. 2014). After alignment and 
filtering, the BEADS algorithm was used to generate normalised ChIP-seq coverage 
tracks (Cheung et al. 2011). 
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 For downstream analyses - aggregate plots, heatmaps, screen shots - 
stage-specific tracks were obtained by averaging normalised signal across two biological 
replicates. Manipulations of genome-wide signal were performed using bedtools 
(Quinlan and Hall 2010), UCSC utilities (Kent et al. 2010), and wiggleTools (Zerbino et 
al. 2014). Computationally intensive steps were managed and parallelised using 
snakemake (Köster and Rahmann 2012). Genome-wide data was visualised using the 
Integrative Genomics Viewer (Robinson et al., 2011; Thorvaldsdóttir et al., 2013). 
 
Identification of accessible sites 
Accessible sites were identified as follows. We first identified concave regions (regions 
with negative smoothed second derivative) from ATAC-seq coverage averaged across 
all stages and replicates. This approach is extremely sensitive, identifying a large 
number (>200,000) of peak-like regions. We then scored all peaks in each sample using 
the magnitude of the sample-specific smoothed second derivative. We used IDR(Q. Li et 
al. 2011) on the scores to assess stage-specific signal levels and biological 
reproducibility, setting a conservative cutoff at 0.001. Final peaks boundaries were set to 
peak accessibility extended by 75bp on both sides. We found that calling peaks using 
paired end or single end data were highly similar, but some regions were captured better 
by one or the other. Developmental ATAC-seq datasets were sequenced paired-end and 
ageing datasets single-end. Peaks were therefore called separately using developmental 
paired-end data, developmental single-end data extended to 150bp and shifted 75bp 
upstream, and ageing (single-end only) data, and then merged. This was achieved by 
successively including peaks from the three sets if they did not overlap a peak already 
25 
.CC-BY 4.0 International licensepeer-reviewed) is the author/funder. It is made available under a
The copyright holder for this preprint (which was not. http://dx.doi.org/10.1101/279158doi: bioRxiv preprint first posted online Mar. 10, 2018; 
 identified in an earlier set. Figure 1 - source data 1 gives peak calls and ATAC peak 
heights at each stage. 
 
Annotation of regulatory elements 
Patterns of nuclear transcription were used to annotate elements. At each stage, 
separately on both strands, we assessed 1) initiating and elongating transcription at the 
site, 2) continuity of transcription from the site to the closest downstream gene, and 3) 
positioning of nearby exons (on the matching strand). WormBase WS260 genome 
annotations - with coordinates backlifted to WBcel215/ce10 (WS220) - were used 
throughout this study. 
To assess for transcription elongation at an accessible site, we counted 5' ends 
of long cap reads upstream (-250:-75), and downstream (+75:+250) of peak 
accessibility. We then used two approaches to identify sites with a local increase in 
transcription elongation. First, we used DESeq2 to test for an increase in downstream vs 
upstream counts ("jump" method). Statistical significance was called at log2FoldChange 
> 1.5, and adjusted p-value < 0.1 (one-sided test). To capture additional regions with 
weak signal ("incr" method), we accepted sites with 0 reads upstream, at least one read 
in both biological replicates downstream, and 3 reads total when summed across both 
biological replicates. 
To assess transcription initiation, we pooled short cap across all six wild-type 
stages, and included two additional embryo replicates from ​(Chen et al. 2013)​. The 
pooled signal was filtered for reproducibility by only keeping signal at base pairs with 
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 non-zero transcription initiation in at least two replicates. We then required the presence 
of at least one base pair with reproducible signal within 125bp of peak accessibility to 
designate an accessible site as having transcription initiation. For every site, we also 
defined a representative transcription initiation mode as the position with maximum short 
cap signal within 125bp of peak accessibility. For sites without reproducible short cap 
signal, we used an extrapolated, "best-guess" position at 60bp downstream of peak 
accessibility. 
We annotated accessible sites as coding_promoter or pseudogene_promoter if 
they fulfilled the following four criteria. 1) The accessible site had transcription initiation, 
and passed at least one of the elongation tests (jump or incr), or passed both elongation 
tests (jump and incr). 2) Transcription initiation mode at the accessible site was either 
upstream of the closest first exon, or, in the presence of a UTR, up to 250bp 
downstream within the UTR. (The closest first exon was chosen based on the distance 
between the 5' end of the first exon and peak accessibility at the accessible site, allowing 
the 5' end of the exon to be up to 250bp upstream or anywhere downstream of peak 
accessibility). 3) The region from peak accessibility to the closest first exon did not 
contain the 5' end of a non-first exon. 4) Distal sites (peak accessibility >250bp from the 
closest first exon) were additionally required to (a) have continuous long cap coverage 
from 250bp downstream of peak accessibility to the closest first exon, and (b) be further 
than 250bp away from any non-first exon. 
We then further attempted to assign a single, lower-confidence promoter to 
genes that were not assigned a promoter so far. For every gene without promoter 
assignments, we re-examined sites that fulfilled criteria (2-4), and were either intergenic, 
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 or within 250bp of the closest first exon. We then annotated the site with the largest jump 
test log2FoldChange as the promoter, if it was also larger than 1. 
Next, sites within 250bp of the 5' end of an annotated tRNA, snoRNA, miRNA, 
snRNA or rRNA were annotated as non-coding_RNA. Intergenic sites more than 250bp 
away from annotated exons that had initiating transcription, and passed the jump test 
were annotated as unknown_promoter. All remaining sites were annotated as 
transcription_initiation or no_transcription based on whether they had transcription 
initiation. 
Elements were then annotated on each strand based on aggregating 
transcription patterns across stages by determining the "highest" annotation using the 
ranking of: coding_promoter, pseudogene_promoter, non-coding_RNA, 
unknown_promoter, transcription_initiation, no_transcription. Element type was then 
defined using the following ranking: coding_promoter on either strand => 
coding_promoter; pseudogene_promoter on either strand => pseudogene_promoter; 
non-coding_RNA on either strand => non-coding_RNA; unknown_promoter on either 
strand => unknown_promoter; transcription_initiation on either strand => 
putative_enhancer; all remaining sites => other_element. Figure 2 - source data 1 gives 
annotation information. 
 
Motif analyses 
Inr and TATA consensus sequences were obtained from (Sloutskin et al. 2015), and 
mapped with zero mismatches using homer (Heinz et al. 2010). 
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Clustering of promoter accessibility 
Regulatory elements with regulated accessibility were determined as follows. All 
elements (n=42,245) were tested for a difference in ATAC-seq coverage between any 
developmental time point or between any ageing time point using DESeq2 (Love, Huber, 
and Anders 2014). Sites with >= 2 absolute fold change and adjusted p-value < 0.01 
were defined as "regulated" (n=30,032 in development and 6,590 in ageing), and 
regulated promoters (n=10,199 in development and 1,800 in ageing) were used in 
clustering analyses. 
For clustering analyses, depth-normalised ATAC-seq coverage of each promoter 
was calculated at each time point in development or ageing. The relative accessibility of 
a regulated promoter was calculated at each time point in development or ageing by 
applying the following formula: 
   ​.og  og l 2  ATACseq coverage  1(  time point  i +  ) − l 2 (mean ATACseq coverage across time points  1) +   
For each promoter, its mean ATAC-seq coverage across time points was calculated 
separately for developmental or ageing time course. Clustering was performed using 
k​-medoids, as implemented in the pam() method of the cluster R package ​(Maechler et 
al. 2017)​. Different numbers of clusters were tested for clustering of regulatory elements 
in developmental and ageing datasets and the ones with the best homogeneity of 
normalized changes in ATAC-seq signals within each cluster was chosen. We manually 
merged two ageing clusters showing comparable accessibility and tissue-specific genes 
enrichment (resulting in the cluster I+H [2]). Clusters labels were determined based on 
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 which tissues showed a strong enrichment for tissue-enriched genes within each cluster 
(> 3.5-fold increase in the proportion of tissue-enriched genes between each tissue).  
To compare accessibility and gene expression, FPM-normalised gene-level read 
counts were calculated using DESeq2, and then averaged across biological replicates. 
For visualisation, relative expression levels were calculated using the approach 
described above for relative promoter accessibility (see formula above), with FPM values 
instead of ATAC-seq coverage values. 
Tissue-specific enrichment analyses used single-cell RNA-seq data from (Cao et 
al. 2017). Genes were considered enriched in a given tissue if they had a fold-change >= 
3 between the first and the second tissues with the highest expression and an adjusted 
p-value < 0.01. GO enrichments were evaluated using the R package gProfileR 
(Reimand et al. 2016). Significant enrichment was set at an adjusted p-value of 0.05, 
and hierarchically redundant terms were automatically removed by gProfileR. 
 
Cluster-specific transcription factors binding enrichment 
Optimal IDR-thresholded transcription factors ChIP-seq peaks datasets were 
downloaded from ENCODE portal. When multiple datasets were available for a given 
transcription factor, peaks from all of the datasets were combined and merged. ChIP-seq 
profiles were manually inspected and datasets showing poor-quality tracks were 
discarded, resulting in a set of 152 transcription factors. 
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 To define TFBS clusters (Figure 1 - figure supplement 1C, Figure 2 - figure 
supplement 1), we extended the TF peak calls to 200bp on either side of the summit, 
and clustered overlapping peak calls using a single-linkage approach. 
Prior to analysis of TF peak enrichment at annotated promoters (Figure 5), any 
promoter overlapping with more than 10 transcription factors peaks was considered as 
“hot” and removed from the initial set of 13,596 annotated promoters, resulting in 8,351 
to be assessed by enrichment analysis. Only transcription factors with more than 200 
peaks overlapping “non-hot” promoters were kept, to remove potentially weak TF peaks 
datasets constituted only of residual “hot” peaks. Following this stringent filtering, 62 
transcription factors could be assayed for binding enrichment. A transcription factor peak 
was assigned to a promoter if any portion of the 400bp region centered at the peak 
summit intersected the promoter. Transcription factor binding enrichment in each cluster 
was estimated using the odds ratio and enrichments with an associated p-value < 0.01 
(Fisher’s exact test) were kept. Transcription factors which did not show enrichment 
higher than 2 in any cluster were discarded. Figure 5 summarizes the transcription factor 
binding enrichment in each cluster during development or ageing. Relative tissue 
expression profiles of each transcription factor at the L2 stage (data from Cao et al. 
2017) was calculated in each tissue by taking the log2 of its expression (TPM) in the 
tissue divided by its mean expression across all tissues. A pseudo-value of 0.1 was first 
added to all the TPM values before calculation of the relative levels of expression.  
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 Construction of transgenic lines 
Transgene constructs were made using three-site Gateway cloning (Invitrogen) as in 
(Chen et al. 2014)​. Site 1 has the regulatory element sequence to be tested, site 2 has a 
synthetic outron ​(OU141; Conrad et al. 1995)​ fused to ​his-58 ​ (plasmid pJA357), and site 
3 has gfp-tbb-2 3’UTR ​(pJA256; Zeiser et al. 2011)​ in the MosSCI compatible vector 
pCFJ150, which targets Mos site Mos1(ttTi5605); MosSCI lines were generated as 
described ​(Frøkjaer-Jensen et al. 2008)​. 
 
Data access 
ATAC-seq, ChIP-seq, DNase/MNase-seq, long/short cap RNA-seq data from this study 
have been deposited in the NCBI Gene Expression Omnibus (GEO) 
(http://www.ncbi.nlm.nih.gov/geo/) under accession number GSE114494. 
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 Figure legends 
Figure 1. Overview of the project. 
(A) Overview of genome-wide assays and time points of developmental and ageing 
samples. For development samples, chromatin accessibility, transcription initiation, 
productive elongation, and chromatin state were profiled in six stages of wild-type 
animals (embryos, four larval stages, young adults). For ageing samples, chromatin 
accessibility and productive transcription elongation were profiled in five time points of 
sterile adult ​glp-1 ​ mutants (Day 1, Day 2, Day 6, Day 9, Day 13). (B) Representative 
screen shot of normalised genome-wide accessibility profiles in the eleven samples. 
 
Figure 2. Annotation of accessible elements. 
(A) Top, strand specific nuclear RNA in each developmental stage monitors transcription 
elongation; plus strand, blue; minus strand, red. Below is transcription initiation signal, 
element annotation coloured as in (B) right, and gene model. (B) Accessible elements by 
annotation class. (C) Left, distribution of the number of promoters and enhancers per 
gene; right, boxplot shows that genes with more promoters also have more enhancers.  
 
Figure 3. Heatmaps of HMs/factors and properties of enhancers and promoters. 
(A) Heatmaps of indicated histone modifications and CV values at coding promoters 
(top), and enhancers (bottom). Elements are ranked by mean H3K4me3 levels. CV 
values are correlated with H3K4me3 levels. (B) Distribution of initiator Inr motif, TATA 
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 motif, and CpG content at coding promoters and enhancers, separated by H3K4me3 
level (top, middle, and bottom thirds). 
 
Figure 4. Shared dynamics of promoter accessibility in development and ageing. 
(A,B) Clusters of promoters showing shared relative accessibility patterns across (A) 
development or (B) ageing. Relative accessibility at each time point was defined by the 
log2 of the depth-normalized ATAC-seq coverage at each time divided by the mean 
ATAC-seq coverage across the time series (see Methods). For each cluster, the 
percentage of associated genes with tissue-enriched expression determined from 
single-cell L2 larval RNA-seq data ​(Cao et al. 2017)​ for each tissue is also shown. (C,D) 
Examples of GO terms enriched in (C) developmental or (D) ageing clusters. 
 
Figure 5. Transcription factor binding enrichment in developmental and ageing 
promoter clusters. 
Transcription factor (TF) binding enrichments in developmental (A) or ageing (B) 
promoter clusters from Figure 4. TF binding data are from modENCODE/modERN 
(Araya et al. 2014; Kudron et al. 2017); peaks in HOT regions were excluded (see 
Methods). Only TFs enriched more than 2-fold in at least one cluster are shown, and 
only enrichments with a p < 0.01 (Fisher’s exact test) are shown. Plots show TF binding 
enrichment odds ratio, relative tissue expression (log2(tissue TPM/mean TPM across all 
tissues)), and tissue expression level TPM. Expression data are from ​(Cao et al. 2017)​. 
42 
.CC-BY 4.0 International licensepeer-reviewed) is the author/funder. It is made available under a
The copyright holder for this preprint (which was not. http://dx.doi.org/10.1101/279158doi: bioRxiv preprint first posted online Mar. 10, 2018; 
 Legends for Figure Supplements 
Figure 1 - figure supplement 1. Comparison of ATAC-seq to concentration courses 
of DNase I-seq and MNase-seq. 
(A) Genomic DNA digested using different concentrations of DNase I (top) or MNase 
(bottom). Red rectangles highlight approximate size ranges subjected to paired-end 
Illumina sequencing. (B) SPMR-normalised coverage of a DNase I concentration series 
(blue tracks), MNase concentration series (green tracks), and ATAC-seq (red track) at 
the ​lin-23 ​ locus. The modENCODE/modERN ChIP-seq peak call pileup (grey track) 
shows a TF binding region upstream of the gene. Different concentrations of nuclease 
show different types of signal. Low concentrations of DNase I and MNase produce a 
peak in the middle of the TF binding region, at the expected NDR (middle vertical bar). 
At higher concentrations, both enzymes show a peak at the -1 and +1 nucleosomes (left 
and right vertical bars). ATAC-seq has a single large peak centered in the middle of the 
TF binding region. (C) Mean normalised coverage at transcription factor binding sites 
defined by clustering modENCODE/modERN peak calls (n=36,389; Methods) in 
ATAC-seq, DNase-seq, and MNase-seq (the latter two are shown at concentrations with 
the highest accessibility enrichment). ATAC-seq shows higher signal than DNase-seq or 
MNase-seq. (D) Normalised read coverage of ATAC-seq prepared from nuclei harvested 
from live (red), or frozen (blue) embryos. 
Figure 2 - figure supplement 1. Comparisons to existing accessibility maps. 
(A) Venn diagrams showing the overlap of transcription factor binding sites defined by 
clustering modENCODE/modERN peak calls (n=36,389; Methods) to accessible sites 
from this study and two previous studies (​(Daugherty et al. 2017)​ and ​(Ho et al. 2017)​). 
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 (B) Comparison of accessible sites defined in this study to accessible sites defined in 
(Daugherty et al. 2017)​. (C) Comparison of accessible sites defined in this study to 
accessible sites defined in ​(Ho et al. 2017)​. (B,C) Leftmost plot shows overlaps between 
accessible sites; remaining plots compare regions found in only one study or both 
studies. Plots show mean profile of modENCODE/modERN peak call pileup, fraction of 
sites with transcription initiation signal (negative values are reverse strand signals), and 
fraction overlapping an exon. (D,E) IGV screenshots of stage-specific accessibility 
profiles and peak calls from ​(Daugherty et al. 2017)​ (top, red), ​(Ho et al. 2017)​ (middle, 
green), and this study (bottom, blue). 
Figure 2 - figure supplement 2. Genomic locations of accessible sites. 
(A) Left: distribution of bases in the ​C. elegans​ genome, partitioned into outronic, exonic, 
intronic, intergenic or mixed, based on the regulatory annotation. Right: distribution of 
genomic region type at accessible sites. (B) Distribution of genomic region at specific 
types of accessible sites. 
Figure 2 - figure supplement 3. Comparison to published TSS maps. 
(A-D) Left: overlap between accessible sites and TSS annotations from (A) ​(Chen et al. 
2013)​; (B) ​(Kruesi et al. 2013)​; (C) ​(Saito et al. 2013)​; (D) ​(Gu et al. 2012)​. Right: 
accessible site annotations of elements that overlap a TSS in the indicated study. TSSs 
were considered to overlap an accessible site if they were located within 150bp of peak 
accessibility. For (Gu et al., 2012), TSSs were clustered using a single-linkage approach 
using a distance threshold of 50bp, and the overlaps are based on those clusters. 
Figure 2 - figure supplement 4. Types of unknown promoters. 
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 (A) Position and orientation of sites annotated as unknown_promoter on the forward or 
reverse strands relative to gene annotations (n=3,026). (B–D) Examples of transcription 
patterns at unknown promoters (B) coding_promoter_antisense, (C) 
genic_region_antisense, (D) intergenic.  
Figure 2 - figure supplement 5. Tests of promoter activity of annotated promoters 
and enhancers 
(A) Comparison of annotations to 23 elements previously shown to function as 
promoters in transgenic assays ​(Merritt et al. 2008; Hunt-Newbury et al. 2007; Chen et 
al. 2014)​.  (B) Indicated elements were fused to his-58-gfp (see Methods) and the 
resulting transgenic strains tested for GFP expression in embryos. Elements were 
cloned in the endogenous orientation relative to their associated gene or in inverted 
orientation, as indicated. In expression strength column, “strong” and “medium” indicate 
high and low level of GFP visible in live embryos; “weak” indicates expression only 
visible by immunofluorescence. (C) Examples of transgene expression. Shown is 
expression driven by the ​ztf-11 ​ promoter and the ​bro-1 ​ enhancer in both orientations; 
DIC image on left, HIS-58-GFP on right. 
Figure 3 - figure supplement 1. Histone marks and motif enrichments sorted by CV 
value. 
(A) As Figure 3A, except that accessible sites were ranked based on CV values, and the 
heatmap additionally includes H3K36me3, aligned at the start of the associated gene 
annotation. (B) As Figure 3B, except that the three groups of promoters and enhancers 
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 were defined based on CV values. Bottom CV represents stable expression and top CV 
regulated expression. 
Figure 4 - figure supplement 1. Characteristics of developmental clusters. 
Clusters of promoters showing shared accessibility patterns across development. The 
first column of plots shows promoter relative ATAC coverage across the time series as 
described in Methods. The second column shows the same information displayed as a 
heatmap, each row representing a promoter. Values are contained within a color scale 
from -2 (dark blue) to 0 (white) to +2 (dark red). The third column shows relative gene 
expression across the same time series as described in Methods, each row representing 
a gene. The same color scale is used here. The boxplots column represents expression 
(in TPM) of clustered genes in individual tissues (data from Cao et al 2017). The barplots 
column represents the percentage of genes within the cluster enriched in each tissue as 
described in Methods. Finally, the horizontal bar plots column shows the top 5 enriched 
GO terms obtained for each cluster from the corresponding list of genes using gProfiler 
as described in Methods. MF=Molecular Function, CC=Cellular Component, 
BP=Biological Process. 
Figure 4 - figure supplement 2. Characteristics of ageing clusters. 
Similar to Figure 4 ​ - ​figure supplement 1 for ageing clusters.  
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 Source data 
Figure 1 - source data 1. Accessible sites identified using ATAC-seq 
● chrom, start, end​ location of the accessible site in bed-style coordinates (ce10) 
● atac_%stage_height​ maximum SPMR-normalised ATAC-seq signal at the peak 
in %stage (one of ​wt_emb ​, ​wt_l1 ​, ​wt_l2 ​, ​wt_l3 ​, ​wt_l4 ​, ​wt_ya ​, ​glp1_d1 ​, ​glp1_d2 ​, 
glp1_d6 ​, ​glp1_d9 ​, ​glp1_d13 ​) 
● atac_source ​ source of the ATAC-seq peak call (see Methods) 
○ atac_wt_pe ​ wt (developmental) ATAC-seq treated as paired-end 
○ atac_wt_se ​ wt (developmental) ATAC-seq treated as single-end 
○ atac_glp1_se ​ glp-1 (aging) ATAC-seq, single-end only 
Figure 2 - source data 1. Regulatory annotation of accessible sites 
● chrom, start, end​ location of the accessible site in bed-style coordinates (ce10) 
● annot​ final regulatory element type, obtained by combining strand-specific 
transcription patterns (see Methods) 
● annot_%strand​ annotation of the strand-specific transcription patterns at the site 
(%strand is either ​fwd ​ or ​rev​) 
● promoter_gene_id_%strand​, ​promoter_locus_id_%strand​, 
promoter_gene_biotype_%strand​ WormBase gene id, locus id, biotype for 
sites annotated as coding_promoter, pseudogene_promoter or non-coding_RNA 
on %strand 
● associated_gene_id​, ​associated_locus_id​ WormBase gene id, locus id of 
genes whose gene body or outron region overlaps the site. These are defined for 
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 for sites annotated as unknown_promoter, putative_enhancer or other_element. 
If a site overlaps multiple genes, all overlaps are reported, separated by commas. 
● tss_%strand​ representative transcription initiation mode on %strand (Methods) 
● scap_%strand_passed​ True or False based on whether the site has 
reproducible transcription initiation (Methods) 
● lcap_%stage_%strand_passed_jump​ True or False based on whether the site 
passed the jump test for elongating transcription (Methods, %stage is one of 
wt_emb ​, ​wt_l1 ​, ​wt_l2 ​, ​wt_l3 ​, ​wt_l4 ​, ​wt_ya ​, ​glp1_d1 ​, ​glp1_d2 ​, ​glp1_d6 ​, ​glp1_d9 ​, 
glp1_d13 ​) 
● lcap_%stage_%strand_passed_incr ​ True or False based on whether the site 
passed the incr test for elongating transcription (Methods) 
Figure 4 - source data 1. Promoter accessibility clusters in development and 
ageing 
● chrom, start, end​ location of the accessible site in bed-style coordinates (ce10) 
● devel_is_dynamic ​ True or False based on whether the site shows differential 
accessibility between any two developmental stages 
● ageing_is_dynamic ​True or False based on whether the site shows differential 
accessibility between any two ageing time points 
● devel_prom_cluster_label​ assigned developmental accessibility promoter 
cluster 
● ageing_prom_cluster_label​ assigned ageing accessibility promoter cluster 
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Figure 2—figure supplement 5
A
bro-1		
enhancer	
ztf-11	
promoter	
Endogenous	
orientation	
Inverted	
orientation	C
locus chr start stop gene	
strand
annotation
tested	
orientation		
relative	to	
gene
Expression
Expression	
strength	
(Strong,medium,
weak)
Embryo	expression Reference Strain	
Name
Genotype
otub-2 I 397755 398120 + prom endogenous Yes strong broad Chen	et	al,	2014 	JA1613 weSi68	II;	unc-119(ed3)	III
hlh-2 I 7194716 7195216 - prom endogenous Yes strong broad,	but	not	in	intestine this	paper JA1652 weSi89	II;	unc-119(ed3)	III
ztf-11 I 9910350 9910850 - prom endogenous Yes strong broad,	but	not	in	intestine this	paper JA1733 weSi142	II;	unc-119(ed3)	III
ztf-11 I 9910350 9910850 - prom inverted Yes medium
broad,	but	not	in	intestine	
(weaker	than	endogenous	
direction)
this	paper JA1727 weSi136	II;	unc-119(ed3)	III
F58D5.5 I 12039662 12040186 + prom endogenous Yes strong broad Chen	et	al,	2014 JA1608 weSi63	II;	unc-119(ed3)	III
F58D5.5 I 12039662 12040186 + prom inverted Yes strong broad this	paper JA1765 weSi145	II;	unc-119(ed3)	III
daf-5 II 14040184 14040697 - prom	+	enh endogenous Yes strong broad Chen	et	al,	2014 JA1620 weSi72	II;	unc-119(ed3)	III	
eif-3b II 14794905 14795250 + prom endogenous Yes strong broad Chen	et	al,	2014 JA1601 	weSi61	II;	unc-119(ed3)	III
T19C3.4 III 623811 624139 - prom endogenous Yes strong broad Chen	et	al,	2014 JA1612 weSi67	II;	unc-119(ed3)	III	
Y71H2AM.20 III 2785938 2786194 - prom endogenous Yes strong broad Chen	et	al,	2014 JA1600 weSi60	II;unc-119(ed3)	III
mtm-3 III 3801252 3801770 - prom endogenous Yes strong broad Chen	et	al,	2014 JA1610 weSi65	II;	unc-119(ed3)	III
hlh-11 III 9619057 9619496 + prom endogenous Yes strong broad Chen	et	al,	2014 JA1609 weSi64	II;	unc-119(ed3)	III
bed-3 IV 9915158 9915437 + prom endogenous Yes 	weak ~20	hypodermal	cellls this	paper JA1712 weSi128	II;	unc-119(ed3)	III
rho-1 IV 16492191 16492669 - unknown	
promoter
endogenous Yes strong broad Chen	et	al,	2014 JA1611 weSi66	II;	unc-119(ed3)	III
egrh-1 X 14840974 14841376 + prom endogenous Yes strong broad Chen	et	al,	2014 JA1614 weSi69	II;	unc-119(ed3)	III
bro-1 I 5187416 5187609 + enh-intronic endogenous Yes medium seam	cells this	paper JA1708 	weSi130	II	;	unc-119(ed3)	III
bro-1 I 5187416 5187609 + enh-intronic inverted Yes weak seam	cells this	paper JA1737 weSi146	II;	unc-119(ed3)	III
hlh-2 I 7195757 7196257 - enh endogenous Yes medium few	anterior	cells this	paper JA1674 weSi108	II;	unc-119(ed3)	III
hlh-2 I 7196571 7197071 - enh endogenous Yes weak 10-20	anterior	cells this	paper JA1663 weSi97	II;	unc-119(ed3)	III
hlh-2 I 7197592 7198092 - enh endogenous Yes medium few	hypodermal	cells this	paper JA1669 weSi103	II;	unc-119(ed3)	III
hlh-2 I 7197592 7198092 - enh inverted Yes medium few	hypodermal	cells	(weaker	
than	endogenous	orientation)
this	paper JA1701 weSi123	II;	unc-119(+)]III
hlh-2 I 7198146 7198646 - enh endogenous Yes medium few	pharyngeal	cells this	paper JA1671 weSi105	II;	unc-119(ed3)	III
hlh-2 I 7198751 7199251 - enh endogenous Yes medium few	pharyngeal	cells this	paper JA1673 weSi107	II;	unc-119(ed3)	III
ztf-11 I 9911508 9912008 - enh endogenous yes weak broad,	most	cells this	paper JA1667 weSi101	II;	unc-119(ed3)	III
bed-3 IV 9910252 9910601 + enh endogenous Yes medium few	anterior	cells this	paper JA1703 weSi125	II;	unc-119(ed3)	III
bed-3 IV 9911938 9912226 + enh endogenous Yes weak ~15	nuclei,	head	and	tail this	paper JA1711 weSi133II;	unc-119(ed3)	III
bed-3 IV 9913192 9913425 + enh endogenous no no	expression this	paper JA1704 weSi126	II:	unc-119(ed3)	III
bed-3 IV 9914205 9914396 + enh endogenous no no	expression this	paper JA1705 weSi127	II;	unc-119(ed3)	III
bed-3 IV 9918007 9918207 + enh-intronic endogenous Yes weak few	hypodermal	cells this	paper JA1707 weSi129	II;	unc-119(ed3)	III
gene chr tested	region	
start
tested	region	
end
length Annotation Reference
daz-1 II 5455759 5456289 552 prom Merritt	et	al,	2008
gld-1 I 7695164 7695660 527 txn	initiation Merritt	et	al,	2008
him-3 IV 6977138 6977484 372 prom Merritt	et	al,	2008
mex-5 IV 13353211 13353674 486 prom Merritt	et	al,	2008
msp-56 IV 9841000 9841495 513 prom Merritt	et	al,	2008
pgl-3 V 4755287 4755970 709 prom Merritt	et	al,	2008
spe-11 I 5332434 5332187 272 no	txn Merritt	et	al,	2008
spn-4 V 6784847 6785394 544 prom Merritt	et	al,	2008
fbf-1 II 6080676 6081758 1114 prom Merritt	et	al,	2008
tag-243 III 4687158 4687357 199 prom Hunt-Newbury	et	al,	2007
atp-2 III 5228403 5228199 204 no	element Hunt-Newbury	et	al,	2007
him-4 X 9717247 9717573 326 no	element Hunt-Newbury	et	al,	2007
lgc-34 II 526514 526671 157 prom Hunt-Newbury	et	al,	2007
daf-5 II 14040184 14040697 514 prom	+	enh Chen	et	al	2014
egrh-1 X 14840974 14841376 403 prom Chen	et	al	2014
eif-3b II 14794905 14795250 346 prom Chen	et	al	2014
F58D5.5 I 12039662 12040186 525 prom Chen	et	al	2014
hlh-11 III 9619057 9619496 440 prom Chen	et	al	2014
mtm-3 III 3801252 3801770 519 prom Chen	et	al	2014
rho-1 IV 16492191 16492669 479 unknown	promoter Chen	et	al	2014
T19C3.4 III 623811 624139 329 prom Chen	et	al	2014
otub-2 I 397755 398120 366 prom Chen	et	al	2014
Y71H2AM.20 III 2785938 2786194 257 prom Chen	et	al	2014
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Figure 4—figure supplement 1, continued
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Figure 4—figure supplement 2
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